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SUMMARY 
N-of-1 trials allow inference between two treatments given to a single individual. Most often, 
clinical investigators analyze an individual’s N-of-1 trial data with usual t-tests or simple 
nonparametric methods.  These simple methods do not account for serial correlation in repeated 
observations coming from the individual. Existing methods accounting for serial correlation 
require simulation, multiple N-of-1 trials, or both. Here, we develop t-tests that account for serial 
correlation in a single individual. The development includes effect size and precision calculations, 
both of which are useful for study planning. We then evaluate and compare their Type I and II 
errors and interval estimators to those of usual t-tests analogues via Monte Carlo simulation. The 
serial t-tests clearly outperform the usual t-tests commonly used in reporting N-of-1 results. 
Examples from N-of-1 clinical trials in fibromyalgia patients and from a behavioral health setting 
exhibit how accounting for serial correlation can change inferences. These t-tests are easily 
implemented and more appropriate than simple methods commonly used; however, caution is 
needed when analyzing only a few observations.  
 
Keywords: Autocorrelation; Cross-over studies; Repeated measures analysis; Single-case 
experimental design; Time-series  
  
1. INTRODUCTION 
Behavioral scientists have used N-of-1 trials for more than a century (Smith, 2012). Guyatt et al. 
(1986) brought these trials, with randomized crossover designs, to the attention of mainstream 
medical research in the 1980s (see also Gabler et al., 2011). In this era of personalized medicine, 
N-of-1 trials are appearing in medical research with increasing frequency (Tate et al., 2016). 
Consequently, guidelines for these studies were added to the Consolidated Standards of Reporting 
Trials (CONSORT) in 2015; see CONSORT Extension for N-of-1 Trials (CENT) (Shamseer et al., 
2015). CENT guidelines call for statistical methods that account for within-subject correlation. 
This call echoes what reviews of N-of-1 studies often note: N-of-1 data exhibit serial correlation 
(e.g. first-order autocorrelation), and most studies fail to account for serial correlation.(McDonald 
et al., 2017; Smith, 2012; Gabler et al., 2011; Lillie et al., 2011). 
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This work develops a formula-based statistical method for N-of-1 studies that accounts for 
serial correlation while using only the data from a single individual to draw inferences. Most 
existing methods emerged with increases in computing power. These methods typically provide 
inference on two types of differences between two treatments: level- and rate-change. Level-
change is when the difference in means is not dependent on the time series of the treatments, 
whereas rate-change is when the difference in means is dependent on the time series of the 
treatments. Rochon (1990) describes a large-sample, maximum likelihood method that evaluates 
both level- and rate-change, but no closed-form estimator exists. Hence, an iterative procedure 
produces the estimates. McKnight et al. (2000) developed a double-bootstrap method for making 
inference on level- and rate-change. Their first bootstrap estimates serial correlation; the second 
uses the estimated correlation to compare two treatments. They provide statistical properties for 
their method, and they focus on trials having as few as 20 or 30 observations. Borckardt and 
company describe statistical properties of the Simulation Modelling Analysis for N-of-1 trials, and 
consider trials having between 16 and 28 observations from an individual (Borckardt and Nash, 
2014; Borckardt et al., 2008). Simulation Modelling Analysis is similar to a parametric bootstrap 
method, with the bootstrap method generating replicates under the null hypothesis. Empirical p-
values for level- and rate-change result. Lin et al. (2016) propose semiparametric and parametric 
bootstrap methods (only one bootstrap needed) for evaluating level- and rate-change. They explore 
the statistical properties of their method for trials having 28 observations. Other N-of-1 methods 
exist, but the methods described here are the only ones we could find that use only the observations 
from a single individual and account for serial correlation.  
All of the methods above are computationally intensive and require either special software or 
substantial statistical expertise. However, researchers conducting N-of-1 trials seem to prefer 
simpler analysis methods. Gabler et al. (2011) reviewed analyses conducted in 108 N-of-1 trials 
and found 52% used visual analysis, 44% used t-tests, and 24% used nonparametric methods (some 
studies used more than one analysis method). Punja et al. (2016) reviewed 100 reports of 
conducted (60%) and planned (40%) N-of-1 trials. Seventy-five of these performed or planned 
statistical analyses: 53% of these 75 used paired t-tests and 32% used a nonparametric method. 
Though several of these simple analysis methods use only the observations from one individual, 
they fail to account for serial correlation. A substantial proportion of researchers using N-of-1 trials 
sacrifice their need for appropriate analyses to their desire for simplicity. Our goal in this work is 
to tend to their analytical needs and desires by developing a simple method that uses only the data 
from a single individual.  
Furthermore, researchers and clinicians typically collect a small number of observations from 
an individual in an N-of-1 trial. In the Gabler et al. (2011) review, the number of treatment blocks 
(e.g., a pair of treatments at one time point) per individual ranged from 1 to 11. The Punja et al. 
(2016) review reported a similar range: 1 – 13 observations per individual. In both studies, the 
median number of treatment pairs was 3. For this reason, we focus primarily on realistically sized 
N-of-1 trials.  
We provide four t-tests for individual differences between two treatments. While using only 
the observations from a single individual, these tests accommodate serial correlation (Section 2); 
we refer to these as “serial t-tests.” Two of these serial t-tests evaluate level-change, and the other 
two evaluate rate-change. Within the two level- and the two rate-change tests, one test assumes 
observations from two treatments are paired in a series over time; we call these “paired serial t-
tests.” The other test assumes one treatment’s observations are independent of the other’s; we call 
these “2-sample serial t-tests.” In Section 3, we use simulation to compare Type I error rates and 
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estimated power between the four serial t-tests and their “usual t-test” analogues that ignore serial 
correlation. Then, we compare the serial t-tests’ estimated power to their theoretical power. In 
Section 4, we illustrate how these tests may be used in clinical-trial and behavioral-health settings. 
We discuss the results in the final section.  
 
2. SERIAL t-TESTS 
We first describe N-of-1 trial or study designs to which our proposed serial t-tests apply. Next, we 
give the general development of the serial t-test, followed by paired and 2-sample serial t-tests for 
level-change, then paired and 2-sample serial t-tests for rate-change. To assist in planning 
realistically sized N-of-1 trials, we provide tables for each test of expected margins of error for 
confidence intervals and detectable effect sizes. Finally, since the serial t-tests require an estimated 
correlation, we recommend a serial correlation estimator.  
 
2.1. Applicable N-of-1 Designs 
The CONSORT extension for reporting N-of-1 trials (CENT) lists several single-case designs that 
have been referred to as N-of-1 trials, but CENT currently only considers multiple 
withdrawals/reversals, “ABAB,” or multiple-crossovers designs as “N-of-1” in its scope (see 
Figure 1 in Vohra et al., 2015; Shamseer et al., 2015). For the purpose of analysis using the serial 
t-tests developed below, our definition of N-of-1 trial designs is broader than that of CENT. These 
serial t-tests may be used in the following N-of-1 study designs to compare two treatments, say A 
and B, using data from only one individual. Given that minimum size requirements are met 
(defined below for each test), the 2-sample serial t-tests may be applied to N-of-1 trials when there 
is one withdrawal/reversal (“AB” or bi-phase), multiple baseline, or changing criterion designs 
(see Figure 1 in Tate et al., 2013). The 2-sample serial t-tests may also be applicable to N-of-1 
studies with pre-post designs. The paired serial t-tests may be used to analyze N-of-1 randomized 
trials with multiple withdrawals/reversals or crossovers, sometimes called alternating treatment 
designs (Tate et al., 2013); i.e., those deemed true N-of-1 trials by CENT guidelines.  
 
2.2. The serial t-statistic 
The general model for a single series of 𝑚  observations coming from an individual is 
𝒀~N(𝑋𝜷,𝑅𝜎2), where 𝑅 is a first-order autoregressive correlation matrix, with element (𝑗, 𝑘) 
defined as 𝜌|𝑗−𝑘| for 𝑗, 𝑘 = 1, 2, … ,𝑚. We refer to 𝜌 as the serial correlation. For the two-sample 
models described below, we assume additional series of observations coming from the individual 
have the same 𝜎2 and 𝜌.  
Constructing the t-statistic requires estimators of 𝜷 and 𝜎2, but not 𝜌 (see Section 2.5). We 
use ordinary least squares (OLS) estimators because, in the end, they provide formula-based test 
statistics that may be computed by those having little statistical expertise. (Generalized least 
squares estimation gives the best linear unbiased estimator of 𝜷 and an unbiased estimator of 𝜎2, 
but requires an iterative process.) The OLS estimator of 𝜷 is ?̂? = (𝑋′𝑋)−1𝑋′𝒀 for 𝑋 of full column 
rank, and is unbiased. Under the assumed model, 𝒀~N(𝑋𝜷,𝑅𝜎2) , ?̂?  has variance 
(𝑋′𝑋)−1𝑋′𝑅𝑋(𝑋′𝑋)−1𝜎2 for a single series of 𝑚 observations. For the design matrices, 𝑋, which 
we define in Sections 2.3 and 2.4, Var(?̂?) is a function of 𝑚 and 𝜌; we write 
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     Var(?̂?) = 𝑐(𝜌) × 𝜎2,  
suppressing dependence on 𝑚 since it is known. 
Turning attention to the variance, 𝜎2 , the OLS estimator is 𝑠2 =
{𝒀′(𝐼 − 𝑃𝑋)𝒀} {𝑚 − rank(𝑃𝑋)}⁄  . However, 𝑠
2  is biased when 𝜌 ≠ 0 ; 𝐸(𝑠2) =
[{𝑚 − tr(𝑃𝑋𝑅)} {𝑚 − rank(𝑃𝑋)}⁄ ]𝜎
2 with tr(𝑃𝑋𝑅) not equal to the rank of the projection matrix, 
𝑃𝑋 = 𝑋(𝑋′𝑋)
−1𝑋′. For the design matrices defined below, the bias is a function of 𝑚 and 𝜌; we 
thus re-write    
     𝐸(𝑠2) = 𝑏(𝜌) × 𝜎2, (1) 
suppressing dependence on known 𝑚. Additionally, we may express 𝑏(𝜌) in terms of the effective 
sample size of the series, 𝑚′, and the number of estimated location parameters, 𝑝:  
     𝑏(𝜌) =
𝑚(𝑚′ − 𝑝)
𝑚′(𝑚 − 𝑝)
 (2) 
(Dawdy and Matalas, 1964). Note, 𝑚′ depends on 𝜌; we omit that dependence though to reduce 
notation burden. Following from Equations 1 and 2, an unbiased estimator of 𝜎2 may be written 
as  
     
?̃?2 =
𝑠2
𝑏(𝜌)
 (3a) 
=
𝑚′(𝑚 − 𝑝)
𝑚 𝑠
2
(𝑚′ − 𝑝)
⁄
 
(3b) 
For the serial t-statistic testing whether scalar 𝛽 = 𝛽0, the standard normal random variable 
is (?̂? − 𝛽0)/√𝑐(𝜌) × 𝜎2 . (Without loss of generality, we henceforth let 𝛽0 = 0.) The 𝜒
2 divided 
by its degrees of freedom is easily identified in Equation 3b and concisely written in Equation 3a. 
The serial t-statistic is then 
     
𝑡𝐷𝐹 =
?̂?
√
𝑐(𝜌) × 𝑠2
𝑏(𝜌)
 
(4) 
with DF = 𝑚′ − 𝑝 . Thus, ?̂? ± 𝑡𝐷𝐹,𝛼 2⁄ √𝑐(𝜌) × 𝑠2 𝑏(𝜌)⁄  provides a (1 − 𝛼)100%  confidence 
interval for 𝛽. 
 
2.3. Paired and 2-sample serial t-tests for level-change 
For the paired serial t-test for level-change, observations from treatments A and B come from a 
series of pairs (Figure 1a). We take the difference in observations from A and B in the same pair 
as our 𝑌 (Figure 1b); since this test is for level-change, we assume the mean of differences, 𝜇𝐴−𝐵, 
does not depend on the series. The mean model is 𝑋𝜷 = 𝟏𝒎[𝜇𝐴−𝐵], with 𝜇𝐴−𝐵 estimated by the 
sample mean, ?̅?𝐴−𝐵. 
The 𝑐(𝜌), 𝑏(𝜌), and 𝑚’ for this and the following 2-sample level-change test are  
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     𝑐𝐿(𝜌) =
𝑚 + 2𝜌𝑚+1 −𝑚𝜌2 − 2𝜌
𝑚2(𝜌 − 1)2
 (5) 
     𝑏𝐿(𝜌) =
𝑚(1 − 𝑐𝐿(𝜌)) 
𝑚 − 1
 (6) 
 𝑚𝐿′ =
𝑚
𝑚 − (𝑚 − 1)𝑏𝐿(𝜌)
 (7) 
where the 𝐿 subscript denotes level-change. The paired serial t-statistic for level-change is then 
 
𝑡𝐷𝐹 =
?̅?𝐴−𝐵
√
𝑐𝐿(𝜌) × 𝑠2
𝑏𝐿(𝜌)
 
(8) 
with 𝐷𝐹 = 𝑚𝐿′ − 1 . Replacing 𝜌  with its estimate, 𝑟  (see Section 2.5), the statistic becomes 
approximately 𝑡𝐷𝐹. We note that the minimum 𝑚 for this test is 4; this is because three parameters 
are estimated: 𝜇𝐴−𝐵, 𝜎
2, and 𝜌.  
 
Figure 1. These data represent N-of-1 trials suitably analyzed with the paired serial t-tests. True means (lines) 
and serially correlated observations (points) from a single individual receiving treatments A and B in pairs. 
Left panels (a, c) are original points; Right panels (b, d) are the differences in the A and B pairs. Top panels (a, 
b) exhibit level-change and bottom panels (c, d) rate-change. 
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For the 2-sample serial t-test for level-change, observations come from a series particular 
to the treatment, and the two series may be treated as independent (Figure 2a). As the test is for 
level-change, we assume the difference between means, 𝜇𝐴 − 𝜇𝐵, does not depend on the series. 
We treat the original two series of observations, 𝑌𝐴 and 𝑌𝐵, as independent, so 
     𝑋𝜷 = [
𝟏𝒎𝑨 𝟎𝒎𝑨
𝟎𝒎𝑩 𝟏𝒎𝑩
] [
𝜇𝐴
𝜇𝐵
].  
As with the paired test, 𝜇𝐴 and 𝜇𝐵 are estimated by the sample means, ?̅?𝐴 and ?̅?𝐵. The t-statistic is 
 
𝑡𝐷𝐹 =
?̅?𝐴 − ?̅?𝐵
√(
𝑐𝐿𝐴(𝜌)
𝑏𝐿𝐴(𝜌)
+
𝑐𝐿𝐵(𝜌)
𝑏𝐿𝐵(𝜌)
) × 𝑠2
 
(9) 
with 𝐷𝐹 = 𝑚𝐿𝐴
′ +𝑚𝐿𝐵
′ − 2 . Replacing 𝜌  with a pooled estimate, ?̅? =
(𝑚𝐴𝑟𝐴 +  𝑚𝐵𝑟𝐵) (𝑚𝐴 +𝑚𝐵)⁄ , the statistic becomes approximately 𝑡𝐷𝐹. For this test, the minimum 
𝑚 requirements are both 𝑚𝐴  and 𝑚𝐵  are 3 or more, and 𝑚𝐴 +𝑚𝐵 ≥ 7, since we estimate the 
overall 𝜎2 as well as 𝜌 and 𝜇 for each treatment.  
 
 
 
Figure 2. These data represent N-of-1 trials suitably analyzed with 2-sample serial t-tests. True means (lines) 
and serially correlated observations (points) from a single individual exhibiting (a) level-change and (b) rate-
change between treatments A and B. 
 
2.4. Paired and 2-sample serial t-tests for rate-change 
For the paired serial t-test for rate-change, observations from two treatments again come from a 
series of pairs (Figure 1c). We take the difference in observations from A and B in the same pair 
as our 𝑌 (Figure 1d); however, since this test is for rate-change, we assume the mean of 𝒀𝑨−𝑩 
depends linearly on the series. Then  
     𝑋𝜷 = [𝟏𝒎 𝒙] [
𝜇𝐴−𝐵
𝛽𝐴−𝐵
] ,  
 where we use 𝒙 centered about 0; i.e., 𝒙′ = (1,2, … ,𝑚) − (𝑚 + 1) 2⁄ . The parameter of interest 
is 𝛽𝐴−𝐵 ; it is estimated by the slope on 𝑥 from a simple linear regression. 
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For the this and the following 2-sample rate-change test, 𝑐(𝜌), 𝑏(𝜌), and 𝑚′ are defined 
asfollows: 
 𝑐𝑅(𝜌) =
12
(𝑚2 − 1)2
(
 
 
 
 
−
6𝜌(𝜌 + 1)2(𝜌𝑚 − 1)
𝑚2(𝜌 − 1)4
+
2𝜌(6𝜌𝑚+1 + 6𝜌𝑚 + 𝜌2 − 2𝜌 + 1)
𝑚(𝜌 − 1)3
−
6𝜌(𝜌𝑚 + 1)
(𝜌 − 1)2
−
2𝑚𝜌
𝜌 − 1
+
𝑚2 − 1
𝑚 )
 
 
 
 
 (10) 
     𝑏𝑅(𝜌) =
1
𝑚 − 2
(𝑚 − 1 −
2𝜌(𝜌𝑚 −𝑚𝜌 +𝑚 − 1)
𝑚(𝜌 − 1)2
−
𝑚(𝑚2 − 1)𝑐𝑅(𝜌)
12
) (11) 
 𝑚𝑅
′ =
2𝑚
𝑚 − (𝑚 − 2)𝑏𝑅(𝜌)
, (12) 
with the 𝑅 subscript denoting rate-change. The t-statistic for the paired serial t-test for rate-change 
is then 
 
𝑡𝐷𝐹 =
?̂?𝐴−𝐵
√
𝑐𝑅(𝜌) × 𝑠2
𝑏𝑅(𝜌)
 
(13) 
where 𝐷𝐹 = 𝑚𝑅′ − 2 and 𝜌 is replaced with its estimate, 𝑟, to get an approximate 𝑡𝐷𝐹. This test 
requires 𝑚 ≥ 5 as four parameters are estimated.  
For the 2-sample serial t-test for rate-change, observations come from a series particular to 
the treatment, and the two series may be treated as independent (Figure 2b). Since the test is for 
rate-change, we assume the means of 𝑌𝐴 and 𝑌𝐵 depend linearly on the series. We treat the original 
two series of observations, 𝒀𝑨 and 𝒀𝑩, as independent series, so the mean model of 𝒀 = [𝒀𝑨, 𝒀𝑩]′ 
is 
     𝑋𝜷 = [
𝑿𝒎𝑨 𝟎𝒎𝑨
𝟎𝒎𝑩 𝑿𝒎𝑩
] [
𝜇𝐴
𝛽𝐴
𝜇𝐵
𝛽𝐵
], (14) 
where 𝑿𝒎∗ = [𝟏𝒎∗ 𝒙𝒎∗] . 𝛽𝐴  and 𝛽𝐵  are estimated with the slopes from an ordinary linear 
regression having the 𝑋𝜷 in Equation 14. The t-statistic is 
 
𝑡𝐷𝐹 =
?̂?𝐴 − ?̂?𝐵
√𝑠2 (
𝑐𝑅𝐴(𝜌)
𝑏𝑅𝐴(𝜌)
+
𝑐𝑅𝐵(𝜌)
𝑏𝑅𝐵(𝜌)
)
 
(15) 
with 𝐷𝐹 = 𝑚𝑅𝐴
′ +𝑚𝑅𝐵
′ − 4  and replacing 𝜌  with its pooled estimate, ?̅? =
(𝑚𝐴𝑟𝐴 +  𝑚𝐵𝑟𝐵) (𝑚𝐴 +𝑚𝐵)⁄  as before, for the approximate 𝑡𝐷𝐹. Here, both 𝑚𝐴 and 𝑚𝐵 must be 
4 or more and 𝑚𝐴 +𝑚𝐵 ≥ 9 in order to estimate the seven parameters.  
 
    
8 
 
2.5. Sample size considerations when planning N-of-1 trials 
Desired precision of estimated effects and/or power dictate the number of observations (𝑚) needed 
from an individual undergoing an N-of-1 trial. Other than Rochon (1990), all of the authors 
reviewed in Section 1 considered power for their proposed methods, but only for specified sample 
sizes and/or effect sizes (McKnight et al., 2000; Borckardt et al., 2008; Lin et al., 2016). Wang & 
Schork (2019) followed up on Rochon’s work, investigating power, but only considered trials with 
𝑚 = 400. None of the aforementioned authors gave guidance on how to compute sample sizes. 
Senn (2017) presented methods for computing sample sizes in studies involving N-of-1 trials, 
given desired power or precision. Unfortunately, Senn’s methods are for computing how many 
trials are needed, which assumes multiple N-of-1 trials are analyzed together; additionally, his 
methods did not account for serial correlation. Percha et al. (2019) developed tools to inform 
experiment design and estimate power by simulating N-of-1 trials under various controlled 
conditions and random effect assumptions; however, their tools do not account for serial 
correlation.  
Our serial t-tests allow precision, sample size, effect size, and power calculations with 
existing routines or functions in standard statistical software (e.g., R, SAS). The assumptions for 
these calculations are the same as for usual t-tests, but also require an assumed serial correlation, 
𝜌.  
Both precision and effects size calculations require values for the significance level, sample 
size (𝑚), and serial correlation (𝜌). Substituting the values of 𝑚 and 𝜌 into the formulae for 𝑐(𝜌), 
𝑏(𝜌), and 𝑚′ from the desired serial t-test, precision, expressed as an expected margin of error for 
a (1 − 𝛼)100%  confidence interval for 𝛽 , is 𝑡𝐷𝐹,𝛼 2⁄ √𝑐(𝜌) × 𝜎2 𝑏(𝜌)⁄ , where 𝜎
2  is often 
replaced by 1, but may also be replaced by an assumed value. For computing an effect size, 𝛿 (in 
𝜎 units), given a specified power, the following steps outline how to use an existing effect size 
calculator for a one-sample t-test.   
 First note the calculator’s noncentrality parameter, 𝛿(𝐶)√𝑚(𝐶), and degrees of freedom, 
DF(𝐶) = 𝑚(𝐶) − 1, where subscript (C) denotes the calculator’s parameters.  
 Using the assumed value of 𝜌, compute DF (a function of 𝑚′), and 𝑐(𝜌) for the desired 
serial t-test.  
 Set 𝑚(𝐶) equal to DF+1. Usually, 𝑚(𝐶) will not be a whole number; the calculator must be 
able to accept positive real numbers for the degrees of freedom parameter (or sample size, 
𝑚(𝐶)). 
 Using 𝑚(𝐶), compute 𝛿(𝐶) with the calculator. 
 Setting the noncentrality parameter for the desired serial t-test equal to calculator’s 
noncentrality parameter, the effect size is 𝛿 = 𝛿(𝐶)√𝑚(𝐶)𝑐(𝜌)  
To assist in planning an N-of-1 trial for which the paired serial t-test for level change (Equation 
8) is the intended analysis. Table 1 gives expected margins of error for 90% confidence intervals, 
and Table 2 gives 𝜇𝐴−𝐵  values (in 𝜎  units) detectable with 0.80 power on a one-sided 0.05 
significance level test. In the supplementary material, we provide R code for generating these 
tables for all 4 serial t-tests allowing users to specify different confidence coefficients and 
power/Type I error values. 
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Table 1. Expected margins of error for 90% confidence intervals (95% one-sided confidence limit) for 𝜇𝐴−𝐵 
from the paired serial t-test for level change in Equation 8; assumes 𝜎2 = 1. 
ρ m = 4 5 6 7 8 9 10 11 12 
0 1.18 0.95 0.82 0.73 0.67 0.62 0.58 0.55 0.52 
0.2 1.81 1.37 1.14 0.99 0.89 0.82 0.76 0.71 0.67 
0.4 3.61 2.38 1.83 1.52 1.31 1.17 1.07 0.99 0.92 
0.6 14.78 7.00 4.43 3.24 2.58 2.16 1.88 1.67 1.52 
0.8 1272.65 214.23 70.60 33.06 19.06 12.55 9.05 6.96 5.61 
 
Table 2. Effect sizes of 𝜇𝐴−𝐵 (in σ units) detectable with 0.80 power on a 0.10 (one-sided 0.) level test, using 
the paired serial t-test for level change in Equation 8.  
ρ m = 4 5 6 7 8 9 10 11 12 
0 1.65 1.36 1.19 1.07 0.98 0.91 0.85 0.81 0.77 
0.2 2.32 1.82 1.54 1.37 1.24 1.15 1.07 1.01 0.96 
0.4 4.08 2.81 2.24 1.91 1.69 1.54 1.42 1.33 1.25 
0.6 13.73 6.97 4.63 3.52 2.90 2.50 2.22 2.02 1.86 
0.8 869.00 164.50 58.54 26.30 16.04 11.05 8.27 6.56 5.43 
 
2.6. Estimating a serial correlation 
The serial t-tests require an estimate of serial correlation, 𝜌. For a 𝜌 estimator, we work with the 
residuals, 𝑒, of the data from their estimated means:  
𝑒𝑗 = 𝑦𝐴−𝐵,𝑗 − ?̅?𝐴−𝐵 for the paired serial t for level-change;  
𝑒𝑖𝑗 = 𝑦𝑖𝑗 − ?̅?𝑖 for the 2-sample serial t for level-change;  
𝑒𝑗 = 𝑦𝐴−𝐵,𝑗 − ?̂?𝐴−𝐵 − ?̂?𝐴−𝐵𝑥𝑗 for the paired serial t for rate-change; 
𝑒𝑖𝑗 = 𝑦𝑖𝑗 − ?̂?𝑖−?̂?𝑖𝑥𝑖𝑗 for the 2-sample serial t for rate-change, 
where 𝑖 = 𝐴, 𝐵  and 𝑗 =  1, 2, … ,𝑚𝑖 . Note ?̅? = 0; this fact simplifies the maximum likelihood 
estimator of 𝜌  to ?̂? = ∑ 𝑒𝑗 × 𝑒𝑗−1
𝑚
𝑗=2 ∑ 𝑒𝑗
2𝑚
𝑗=1⁄ . However, ?̂?  has bias of 
−2𝜌 (𝑚 − 1) + 𝑂(𝜌𝑚−2)⁄  (Thornber 1967). For small sample sizes, bias is substantial. We 
sought another estimator of 𝜌.  
Solanas et al. (2010) evaluated performance of ten serial correlation estimators. 
Importantly, they considered sample sizes between 5 and 20. Among the ten estimators, they found 
Fuller’s (1996) estimator, 
 𝑟 = ?̂? +
(1 − ?̂?2)
𝑚 − 1
 (16) 
which corrects for bias in ?̂?, had comparatively low mean squared error and bias over positive 𝜌, 
but also performed well for negative 𝜌. The authors particularly recommended Fuller’s estimator 
when sample size is small (≤ 10) and positive serial correlation is expected. For these reasons, we 
use 𝑟 as our serial correlation estimator. We note that for the 2-sample tests, two 𝜌 estimates are 
computed, one for series A and one for series B, and their average taken after weighting by each 
series length. 
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3. MONTE CARLO STUDY EVALUATING TYPE I ERROR, POWER, AND  INTERVAL ESTIMATION 
3.1. Description of Monte Carlo study 
We conducted a Monte Carlo study to evaluate Type I error rates, power, and confidence interval 
width estimation for the serial t-tests. For comparison, we also evaluated the same for the usual t-
tests. Because researchers tend to collect a small number of observations from one individual in 
an N-of-1 trial, we primarily considered 𝑚 from the minimum required up to 12; however, we also 
included 𝑚  values of 30, 50, and 100 to evaluate large sample properties. We chose serial 
correlation values of 𝜌 ∈ {−0.33, 0, 0.33, 0.67}. Variance remained constant across treatments 
and series at 𝜎2 = 1. For paired t-tests, we chose the correlation in pairs to be 𝜌𝑝𝑎𝑖𝑟 ∈ {0.33, 0.67}; 
2-sample t-tests had 𝜌𝑝𝑎𝑖𝑟 = 0. For level-change tests, mean structure was E(𝑌) = 1; for rate-
change tests, mean structure was E(𝑌) = 𝜇 + 𝛽𝑥, where 𝜇 = 0 and 𝛽 = 1. For each combination 
of the four test types, 𝑚, 𝜌, and 𝜌𝑝𝑎𝑖𝑟, we simulated data for 10,000  individuals to maintain Monte 
Carlo error within 0.01 when estimating proportions (with 95% confidence).  
 
3.2 Results 
For level-change, the paired serial t-test has its usual analogue in the 1-sample or Student’s t-test, 
and the commonly known 2-sample t-test is analogous to the 2-sample serial t-test. For rate-change, 
the paired serial t-test has its usual analogue in the t-test of a slope in simple linear regression 
(equivalently, a test of the Pearson correlation coefficient); and the usual t-test for a difference in 
slopes between two treatments is analogous to the 2-sample serial t-test.    
Type I error. We estimated Type I error rates for one-sided 5% significance level tests. The 
results were similar within the level-change tests and within the rate-change tests. First, the level-
change tests: When there is no serial correlation (𝜌 = 0), Type I errors for both the paired and 2-
sample tests are at or within a percentage point of nominal levels. The analogous usual tests are at 
nominal levels as expected. Across all non-zero correlation values, Type I errors are consistently 
closer to nominal than those for the usual tests. Further, as 𝑚 increases, Type I errors for the serial 
tests approach nominal, while those for the usual tests show no improvement or get worse. Type I 
errors for negative 𝜌 are reasonably close (within a couple of percentage points) to a nominal 5% 
for the paired and 2-sample tests, respectively (Figure 3a; see Figure S1a in supplementary material 
for 2-sample test results). For moderately positive 𝜌, Type I errors become reasonable before 𝑚 =
30 for both paired and 2-sample; for high ρ, at some point between 𝑚 = 30 and 𝑚 = 50 for both.  
Patterns of results for rate-change serial tests differ from those for level-change, but within 
the rate-change tests, results for the paired and 2-sample are similar. At the smallest values of 𝑚, 
Type I errors from the serial tests are higher than their usual t analogues. But by 𝑚 = 7 for high 
positive 𝜌 and 𝑚 = 9 for moderate positive 𝜌, the serial tests perform better than the usual tests 
(Figures 4a; see Figure S2a in supplementary material for 2-sample test results). For negative 𝜌, 
the serial tests are near nominal level. When there is no serial correlation (𝜌 = 0), the two serial 
tests reject too often for small 𝑚 (𝑚 ≤ 12), but approach nominal by 𝑚 = 30. Type I errors for 
usual t-tests (except when 𝜌 = 0) are only better than the serial tests for small 𝑚  (𝑚 ≤ 8), 
thereafter, usual’s Type I errors tend to diverge from nominal level.   
Regarding moderate vs high 𝜌𝑝𝑎𝑖𝑟 values in the paired t-tests for level- and rate-change, 
differences in Type I errors are minimal, with the largest difference across 92 relevant Monte Carlo 
configurations being < 1.2 percentage points for serial tests and < 1.5 for usual tests.  
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Figure 3. Paired t-test for level-change. Type I error (top) and theoretical effect size, δ, computed using 
Equation 8 for 80% power with a one-sided 5% significance level test for a given 𝑚 (middle). Ratios (bottom) 
of serial and usual δ (estimated from simulation) to the theoretical δ under same conditions as the theoretical δ. 
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Figure 4. Paired t-test for rate-change. Type I error (top) and theoretical effect size, δ, computed using Equation 
13 for 80% power with a one-sided 5% significance level test for a given 𝑚 (middle). Ratios (bottom) of serial 
and usual δ (estimated from simulation) to the theoretical δ under same conditions as the theoretical δ.  
 
Power. For all four test types, due to the inflated Type I errors for positive 𝜌, power 
estimates – and therefore effect size estimates – are likely optimistic for both serial and usual tests. 
The inverse is true for negative correlations. Using the serial t-test formulas (Equations 8, 9, 13, 
15), we can calculate theoretical effect sizes (𝛿, expressed in terms of 𝜎) required to achieve a 
desired amount of power. Figures 3b, 4b, S1b, S2b display the 𝛿 detectable with 80% power with 
a one-sided 5% significance level test for the given 𝑚 and 𝜌 value. With the simulated data, we 
estimated the actual 𝛿 detectable under the same assumptions using the serial t-tests; we likewise 
estimated the actual 𝛿 detectable under the same assumptions using the usual t-tests. Then we 
calculated the ratio of actual to theoretical 𝛿 for the serial and usual tests (Figures 3c, 4c, S1c, S2c). 
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This ratio indicates how realistic the serial and usual tests are, with a ratio of 1 being most realistic; 
i.e., at theoretical 𝛿. For all four test types, across all values of non-zero correlation, the ratios of 
serial to theoretical 𝛿 are closer to 1 than the ratios of usual to theoretical by 𝑚 = 6, and approach 
unity as 𝑚 increases, while those for the usual test do not. When there is no correlation (𝜌 = 0), 
the usual:theoretical ratio is at 1, as it should be. The discrepancy in the serial:theoretical ratio 
stems from estimating the “0” correlation, but these ratios also  approach 1 with increasing 𝑚. 
Confidence intervals. We estimated the expected margins of error for 90% confidence 
intervals for the serial t and their usual t analogues, and compared these to the mean of 
𝑠 × 𝑡𝐷𝐹,𝛼 2⁄ √𝑐(𝜌) 𝑏(𝜌)⁄ ; see Table 3. For all but the smallest 𝑚, when 𝜌 ≠ 0, the margins of error 
from the serial t were closer to theoretical than those based on the usual t. Further, as 𝑚 increased, 
the serial t’s margins of error converged to the theoretical; whereas the usual t’s margins of error 
will not converge. 
 
Table 3. Factors by which the expected margin of error for a 90% confidence interval (95% one-sided 
confidence limit) is overestimated or underestimated for select sample sizes (𝑚). 
 Test Paired test for level change  2-sample test for level change 
𝜌 type 𝑚 = 4 8 12 100  2𝑚 = 8 16 24 200 
-
0.33 
serial 2.33 1.25 1.14 1.01  1.46 1.18 1.11 1.01 
 usual 1.66 1.49 1.46 1.41  1.50 1.44 1.43 1.41 
0.00 serial 2.00 1.21 1.09 1.00  1.19 1.05 1.03 1.00 
 usual 1.00 1.00 1.00 1.00  1.00 1.00 1.00 1.00 
0.33 serial 1.22 1.11 1.04 1.00  0.80 0.89 0.92 0.99 
 usual 0.43 0.59 0.64 0.70  0.57 0.65 0.67 0.71 
0.67 serial 0.11 0.55 0.78 0.98  0.24 0.52 0.66 0.96 
 usual 0.03 0.17 0.26 0.42  0.15 0.29 0.34 0.43 
           
 Test Paired test for rate change  2-sample test for rate change 
𝜌 type 𝑚 = 5 8 12 100  2𝑚 = 10 16 24 200 
-
0.33 
serial 1.14 1.09 1.05 1.00  1.06 1.06 1.04 1.00 
 usual 1.55 1.44 1.41 1.41  1.40 1.38 1.38 1.40 
0.00 serial 0.85 0.96 0.97 0.99  0.83 0.91 0.94 0.99 
 usual 1.00 1.00 1.00 1.00  1.00 1.00 1.00 1.00 
0.33 serial 0.45 0.71 0.83 0.98  0.55 0.71 0.80 0.97 
 usual 0.47 0.60 0.65 0.70  0.62 0.67 0.69 0.71 
0.67 serial 0.04 0.23 0.45 0.94  0.17 0.37 0.51 0.93 
 usual 0.04 0.16 0.26 0.43  0.18 0.31 0.36 0.43 
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4. EXAMPLES 
4.1. Determining benefit of amitriptyline in fibromyalgia 
Jaeschke et al. (1991) reported results from 23 N-of-1 randomized control trials of amitriptyline 
vs placebo in fibromyalgia patients. Each patient entered an open trial of amitriptyline lasting 
between 3 and 12 weeks. If there was perceived benefit from amitriptyline, the patient began a 
double-blind multiple crossover trial. Order of treatment with amitriptyline or placebo was 
randomized within each of three to six pairs. A pair of treatments lasted four weeks, with two 
weeks for each treatment. At the end of each week, the patient completed a 7-item questionnaire 
evaluating severity of symptoms, with each item on a 7-point scale. The two resulting scores within 
the two-week period were averaged, and the difference between the two treatments’ scores within 
the pair served as the primary outcome. The authors used a one-sided (usual) paired t-test to 
determine benefit of amitriptyline. We re-analyzed their data with the paired serial t-test for level 
change and report one-sided p-values in Table 4. However, since this serial t-test requires at least 
4 pairs of treatments, we could use only 6 of the original 23 patients.   
 
Table 4. N-of-1 randomized control trial data from Jaeschke et al. (1991).  
 
 
 
Patient 
Consecutive pairs of mean 
“active vs placebo” 
differences in 7-item 
questionnaire 
 
 
 
Mean† 
 
 
 
SD 
 
 
 
Serial r 
 
 
 
Usual P 
 
 
 
Serial P 
9 0.05/-0.22/0.57/0.36 0.19 0.35 0.24 ‡0.10 0.25 
18 0.64/1.08/-0.36/0.79/-
0.64/1.50 
0.50 0.83 -0.49 0.10 0.02 
23 1.22/1.07/-0.08/0.50 0.68 0.59 0.38 ‡0.06 0.17 
17 -0.08/0.86/1.07/1.15 0.75 0.57 0.41 0.04 0.15 
15 0.86/1.43/0.65/1.86 1.20 0.55 -0.42 0.01 <0.01 
12 4.29/3.15/0.78/4.49 3.18 1.70 -0.07 0.02 0.01 
† Positive means indicate an improvement while taking amitriptyline. Table values in columns 1, 2, and 6 were 
reproduced from Table 1 on pg 449 of Jaeschke et al. (1991). ‡ Based on the data, the usual paired t-test returns 
one-sided p-values of 0.18 for Patient 9 and 0.05 for Patient 23.    
 
Among the 23 patients (17 not reported here because they had only 3 observations), the 
pattern of final decisions on amitriptyline continuance was “continue” if the one-sided p-value in 
favor of amitriptyline was ≤ 0.15, and discontinue otherwise (Jaeschke et al., 1991). Patients 9, 
23, and 17 all exhibited positive serial correlation, which means their SDs were likely 
underestimated and effective sample sizes overestimated. Had the paired serial t-test (for level-
change) been used instead of the usual paired t-test, decisions for Patients 9 and 23 would have 
been reversed, and Patient 17 would have been on the cusp. The remaining three patients (18, 15, 
and 12) exhibited negative serial correlation, and the serial t-test corroborated the decisions made 
using the usual t-test.  
Zucker et al. (1997) re-analyzed these same data to illustrate a hierarchical Bayesian model 
for N-of-1 trials that combined results from all 23 patients to make both population and individual 
inferences. Their model produced individual posterior probabilities of amitriptyline benefit, say 
𝑝(𝐴|𝑦) , with values closer to 1 indicating benefit. Among the 23 patients, the physician 
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recommended 13 to continue. The minimum 𝑝(𝐴|𝑦) in these 13 was 0.85. All 6 patients in our 
Table 4 had 𝑝(𝐴|𝑦)  ≥  0.85; see Table 1 in Zucker et al. (1997). However, the Bayesian model 
did not account for serial correlation. Unfortunately, we cannot know whether 𝑝(𝐴|𝑦) would have 
changed for our 6 patients had the Bayesian model accounted for serial correlation. In summary, 
the serial t-test gave a more conservative inference on amitriptyline benefit than the original (usual) 
paired t-test and subsequent Bayesian model.   
 
4.2. Change in delay discounting after treatment for opioid dependence 
Landes et al. (2012) evaluated each of 159 patients for change in delay discounting – a measure of 
impulsivity – between pre- and post-treatment for opioid dependence. Just prior to starting, and at 
the end of a 12-week treatment regimen, patients completed a delay discounting task. The task 
presented eight series of choices; one series for each of eight hypothetical delays. In each series, 
the patient was offered choices between a hypothetical $1,000 available after the specified delay 
or an adjusting amount of hypothetical money available immediately. Each series continued until 
an indifference point was determined for the specified delay. An indifference point is the percent 
of the delayed amount the patient deems equivalent to an immediately available amount. Table 5 
contains one patient’s indifference points at the indicated hypothetical delays in a discounting task 
complete before (pre) and after (post) a 12-week treatment for opioid dependence. Pre- and post-
treatment differences also are provided. Ordinary least squares standard deviation, 𝑠, and Fuller’s 
serial correlation estimate, 𝑟, are based on the indicated model in this paper: level- or rate-change.   
To analyze each patient’s pre- and post-treatment series of indifference points, Landes et 
al. (2012) used a regression model particular to delay discounting data, and described more fully 
in Landes et al. (2010). (We note their regression model assumed all indifference points were 
mutually independent.) For each patient, they tested, at the 0.05 level, whether discounting post-
treatment differed from discounting pre-treatment. We re-analyze their data here. 
 
Table 5. Example of indifference points from discounting tasks completed pre- and post-treatment for opioid 
dependence by Patient #1390.  
Hypothetical 
delay 
1 
day 
1 
wk 
2 
wks 
1 
mth 
6 
mth 
1  
yr 
5  
yr 
25 
yr 
Level-change Rate-change 
𝑠 𝑟 𝑠 𝑟 
Pre-
treatment 
92 76 68 58 50 38 18 2 
34.9 0.69 12.4 0.46 
Post-
treatment 
98 92 90 84 72 56 2 2 
Difference -6 -16 -22 -26 -22 -18 16 0 14.2 0.50 13.7 0.32 
 
Their N-of-1 design matches a bi-phasic design; hence, we apply the 2-sample serial t-tests. 
Since it is unknown whether patients may have experienced level- or rate-change, we tested for 
both at the 𝛼 2⁄ = 0.025  level (i.e., a Bonferroni-corrected 0.05 level). If neither test was 
significant, we interpreted the patient’s discounting as having no change; otherwise, the patient’s 
discounting changed between conditions. Table 6 shows the number of patients discounting 
differently between pre- and post-treatment as determined by the original regression method 
(Landes et al., 2012) and by the serial t-tests. Table 6 also contains the three quartiles of 𝑟 under 
each of the serial t-test.  
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Using the 2-sample serial t-tests, we found post-treatment discounting to differ from pre-
treatment in 22 patients (Table 6). Unsurprisingly, this is less than the 69 patients who were found 
to have changed discounting using the original regression method, where everything was assumed 
to be independent (Landes et al., 2012; Landes et al., 2010). Landes and Tang (in preparation) 
examined Type I error rates of the regression method, along with other methods for detecting 
within-individual change in delay discounting, and found Type I error rates for nominal 5% tests 
to be about 15% when true serial correlations were 0.30. In their work, Landes and Tang also 
recommended pairing responses from two discounting tasks by delay after finding empirical 
evidence that correlations of paired delays among tasks were, on average, between 0.25 (N = 394) 
and 0.52 (N = 483). Therefore, we re-analyzed with the paired serial t-tests, again testing for both 
level- and rate-change at the 𝛼/2 level. This time, we found that 37 patients changed discounting 
(Table 6). Again, this is less than the number of participants who were found to have changed 
discounting using the original regression method due to the Type I errors being closer to nominal 
with the paired serial t-tests. Also, because we account for the correlation between pre- and post-
treatment, we find more patients changed than we found in the 2-sample serial t-tests, which 
assumes that pre- and post-treatment discounting are uncorrelated. This is because the paired serial 
t-tests have greater power than the 2-sample serial t-tests when the two samples are truly correlated. 
 
Table 6. Number (percent) of 119† patients discounting differently between pre- and post-treatment.  
N-of-1 test Number significant (%) Median 𝑟 (25%, 75%) 
Original regression method 69 (58) --- 
2-sample serial combined 22 (18) --- 
   2-sample serial t-tests for level-change      8 (7) 0.61 (0.44, 0.69) 
   2-sample serial t-tests for rate-change      16 (13) 0.22 (0.02, 0.34) 
Paired serial t-tests combined 37 (31) --- 
   Paired serial t-tests for level-change       21 (18) 0.34 (0.01, 0.56) 
   Paired serial t-tests for rate-change       19 (16) 0.04 (-0.19, 0.32) 
†Out of 159 participants, 3 had two or more sets of data for a single assessment, and 37 exhibited no 
variability in their indifference points in at least one of the assessments; thus, we excluded these 40 patients.  
   
Returning to Table 5, the original regression indicated Patient #1390’s post-treatment 
discounting had significantly decreased from pre-treatment levels ( 𝑡14 = −2.58, 𝑝 = .022 ). 
Treating the pre- and post-treatment discounting datasets as mutually independent, the 2-sample 
serial t-tests for level- and rate-change did not find sufficient evidence this patient had changed 
(level-change 𝑡2.29 =  0.27, 𝑝 = .808 ; rate-change  𝑡3.98 = −0.61, 𝑝 = .573 ). Pairing post-
treatment with pre-treatment indifference points, and using the paired serial t-tests on the 
differences also failed to find a statistical change in this patient (level-change 𝑡2.22 = −1.32, 𝑝 =
.307; rate-change  𝑡2.94 =  0.91, 𝑝 = .432). For each serial t-test considered, the estimated serial 
correlations ranged from moderate (0.32) to strong (0.69). The original assumption of 
independence in these data likely led to underestimation of relevant variability and inflation of the 
effective sample size.   
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5. DISCUSSION 
Current methods that account for serial correlation in N-of-1 data are computationally intensive 
and often require significant statistical expertise to implement. The serial t-tests developed in this 
paper can accommodate researchers’ preferences for simpler methods while still accounting for 
serial correlation. Type I errors for the serial t-tests are closer to nominal level than those for the 
usual t-tests and attain nominal at large 𝑚. Power for the serial t-tests is more realistic (i.e., closer 
to power computed using the proposed t-statistics) than that for the usual t-tests; the serial tests 
also attain theoretical power at large 𝑚. Margins of error based on the serial t-statistics converge 
to expected width as 𝑚 increases; usual t’s margins of error were generally wider when 𝜌 ≠ 0, and 
will not attain expected width no matter the size of 𝑚 . These serial t-tests can be easily 
implemented by those having only a first course in applied statistics, as they are formulas with no 
computationally intensive methods needed.  
Limitations. While the serial t-tests demonstrate better Type I error rates, power, and 
confidence interval width estimation than the usual t-tests often used in N-of-1 trials, Type I error 
is still substantial, power optimistic, and interval widths biased for small 𝑚. This is mainly due to 
the inaccuracy that remains in estimating 𝜌. Although 𝑟 is bias-corrected, bias still exists; the bias 
is towards 0 for level-change tests, and is negative for rate-change tests. Type I errors are affected 
by the biased 𝑟 through the standard errors and degrees of freedom, both functions of 𝜌. The effect 
of this bias on Type I errors come more through the estimated degrees of freedom than through 
the standard errors. However, increasing 𝑚 improves inflated Type I error, optimistic power, and 
biased margins of error for serial t-tests, particularly for the level-change tests; these 3 properties 
do not improve in the usual t-tests.  
In the rate-change tests, the estimation of 𝜌 has a strong negative bias. Type I error inflation 
for these tests is more than that in level-change tests, even with a large number of observations. 
Further work is needed to correct for the bias in the 𝜌 estimator before these tests may be applied 
to clinical use. 
Although the serial t-tests do not account for carryover effects, the absence of carryover 
effects is often assumed in applications of N-of-1 trials (Shamseer et al. 2015); nevertheless, users 
need to carefully consider experiment designs that limit any carryover effect that may arise when 
comparing treatments. These serial t-statistics assume that observations are equally spaced in time, 
with no missing observations. For unequally spaced observations, the estimator of 𝜌 will be biased 
toward 0. Variance is also assumed to be homogeneous, which is common for most t-test 
applications. For N-of-1 trials, this assumption is likely not unrealistic; see Table 1 of Rochon 
(1990) for an example.  
The 2-sample serial t-tests assume independence between conditions A and B; however, 
since the data come from the same person, this assumption likely is not true, as illustrated when 
pairing observations from separate discounting tasks by delay (Section 4.2). When possible, for N-
of-1 trials with treatments occurring one after the other (as in bi-phasic, pre-post, and ABAB 
designs), planning the same series for both treatments will allow the use of paired serial t-tests, 
which can have greater power when data between the two treatments are truly pair-wise correlated. 
Implications. As reported by recent reviews of N-of-1 trials, the median series size (i.e., 
𝑚) per treatment is 3 (Gabler et al. 2011, Punja et al. 2016). However, at least 3 data points are 
needed for estimating parameters 𝛽, 𝜎2, and 𝜌, leaving none for error degrees of freedom. That is, 
𝑚 should be at least 4 in level-change tests and at least 5 in rate-change tests. Users of these tests 
should be aware of these limitations and carefully consider the size of 𝑚. 
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These serial t-tests provide an easy and familiar way to compute effect sizes for a given 𝑚 
that will attain a desired amount of power; a priori precision calculations are also straight-forward. 
Such computations give rigor to planning a single N-of-1 trial or study. We note, of the very few 
N-of-1 studies we found that provided information on sample size calculations, the “sample size” 
considered only the number of N-of-1 trials that were needed, rather than 𝑚 , the number of 
observations in a single N-of-1 trial. We found no studies using N-of-1 trials that considered 
precision of estimates for an individual trial in their study planning.  
For many types of treatments, individual responses are known to differ. Some patients 
respond well to certain treatments while others show little benefit. This is known as heterogeneity 
of treatment effects. N-of-1 trials evaluate treatment effects on an individual basis; thus eliminating 
the need to account for heterogeneous treatment effects in analyses. In addition, some patients may 
be quite variable in their responses, whereas others respond more predictably. The reasons for 
these heterogeneous treatment effects and variances are not well understood. Therefore, it is 
important to have an easy-to-use statistical method to identify an appropriate treatment for a 
particular patient and to also give a more accurate (less-biased) estimate of variance (see Equation 
3). Better evaluation of these patient-specific parameters may also help in understanding the 
mechanism behind these varying effects.  
These serial t-tests are an improvement over often-employed usual t-tests and other simple 
methods which fail to account for serial correlation. Additionally, the serial t-tests are easy for 
researchers to implement. Further work is still needed to adjust for N-of-1 trials with few 
observations, particularly for rate-change tests. Nevertheless, we believe these serial t-tests will 
make appropriate analyses for N-of-1 trials more accessible to researchers, and allow them to make 
better decisions for individuals undergoing N-of-1 trials.  
 
6. SUPPLEMENTARY MATERIALS 
 
Supplementary material, including all software code and data used in this paper, are available at 
github.com in the rdlandes/red-face repository; see files starting with “N-of-1”.   
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Figure S1. 2-sample t-test for level-change. Type I error (top) and theoretical effect size, δ, computed using 
Equation 9 for 80% power with a one-sided 5% significance level test for a given 𝑚; note, 𝑚𝐴 = 𝑚𝐵 (middle). 
Ratios (bottom) of serial and usual δ (estimated from simulation) to the theoretical δ under same conditions as 
the theoretical δ. 
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Figure S2. 2-sample t-test for rate-change. Type I error (top) and theoretical effect size, δ, computed using 
Equation 15 for 80% power with a one-sided 5% significance level test for a given 𝑚; note, 𝑚𝐴 = 𝑚𝐵. Ratios 
(bottom) of serial and usual δ (estimated from simulation) to the theoretical δ under same conditions as the 
theoretical δ. 
